que es el medicamento semaglutide A fines del año 2025 , la FDA ( USA) aprobó uso de la molécula semaglutida en dosis de 25 mg por día para el tratamiento de los trastornos del peso Especialistas en obesidad advierten contra

Recalls & Warnings July 10, 2012 Children's Probiotics Recalled Due to Potential Salmonella Contamination On July 9, 2012, Sedona Labs announced the voluntary recall of certain lots of iFlora Kids Multi-Probiotic and iFlora 4-Kids Powder distributed between 3/16/2011 and 5/3/2012 due to potential contamination with Salmonella

A US Food and Drug Administration advisory committee is scheduled to meet in July 2026 to consider whether pharmacies should be permitted to compound and sell seven unapproved peptides, with BPC-157 among them

Ensure they come with certificates of analysis (COAs) confirming their purity

Nonetheless, dosage adjustments often mitigate these concerns, emphasizing the importance of medical supervision